The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Novel Approaches to Drug Discovery, 2010Optimizing Metalloporphryins for Clinical Development Supplement
Promising Outcomes of Original Grant:
The overall goal of this ongoing proposal is to determine if a newly developed series of metalloporphyrins designed to penetrate blood brain barrier shows promise... -
MJFF Research Grant, 2010Technology for Clinicogenetic Studies of LRRK2 G2019S in Tunisia
Objective/Rationale:
We seek to create and enhance a secure database, accessible by collaborators with customizable, user-friendly, web-based entry for clinical, genetic and pedigree information. This... -
MJFF Research Grant, 2010The Parkinson's Progression Markers Initiative (PPMI)
Objective/Rationale:
Currently there is no definitive diagnostic test for Parkinson’s disease (PD) in a live patient, and no way to track disease progression on a biological level. These gaps have... -
Rapid Response Innovation Awards, 2010Testing Whether Alpha-Synuclein is Modified by 4-hydroxy-2-nonenal in the Human Brain
Promising Outcomes of Original Grant:
The major goal of our grant application was to test whether a protein known as alpha-synuclein becomes toxic to dopamine-secreting nerve cells when it is modified... -
MJFF Research Grant, 2010The Role of LRRK2 in Neurotransmission
Objective/Rationale:
Parkinson disease involves loss of the neurochemical dopamine, and many of the motor symptoms are attributed to a dopamine deficit in the brain region called the striatum. Recent... -
Novel Approaches to Drug Discovery for Parkinson's Disease, 2010Cerium Oxide Nanoparticles in Treatment of Parkinson's Disease
Promising Outcomes of Original Grant:
In our 2009-2010 proposal, we hypothesized that pretreatment of a pre-clinical model with cerium oxide nanoparticles would be neuroprotective in the MPTP-pre...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.